SafeHeal
Private Company
Total funding raised: $2.5M
Overview
SafeHeal is a French-American medtech company developing the Colovac device, an endoluminal bypass system designed to protect colorectal anastomoses and prevent dangerous post-surgical leaks. The company has achieved European MDR approval for Colovac and is conducting a pivotal IDE study in the U.S., having also received FDA Breakthrough Device designation. Led by an experienced CEO with a commercialization background, SafeHeal is positioned to address a significant unmet need in colorectal surgery recovery, aiming to improve patient outcomes and reduce the burden of temporary ostomies.
Technology Platform
Endoluminal bypass sheath technology for the protection of surgical anastomoses from fecal content.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The market for dedicated anastomosis protection devices is emerging. Competition may come from established surgical sealant and staple line reinforcement products used off-label, or from new entrants developing similar bypass technologies. SafeHeal's first-mover advantage with EU MDR approval and Breakthrough Device designation is a key differentiator.